Literature DB >> 33127840

The multifaceted functions of ATG16L1 in autophagy and related processes.

Noor Gammoh1.   

Abstract

Autophagy requires the formation of membrane vesicles, known as autophagosomes, that engulf cellular cargoes and subsequently recruit lysosomal hydrolases for the degradation of their contents. A number of autophagy-related proteins act to mediate the de novo biogenesis of autophagosomes and vesicular trafficking events that are required for autophagy. Of these proteins, ATG16L1 is a key player that has important functions at various stages of autophagy. Numerous recent studies have begun to unravel novel activities of ATG16L1, including interactions with proteins and lipids, and how these mediate its role during autophagy and autophagy-related processes. Various domains have been identified within ATG16L1 that mediate its functions in recognising single and double membranes and activating subsequent autophagy-related enzymatic activities required for the recruitment of lysosomes. These recent findings, as well as the historical discovery of ATG16L1, pathological relevance, unresolved questions and contradictory observations, will be discussed here.
© 2020. Published by The Company of Biologists Ltd.

Entities:  

Keywords:  ATG16L1; Atg16; Autophagosome; Autophagy; Lipid binding; Membrane recruitment; Phagophore; Single-membrane lipidation

Year:  2020        PMID: 33127840     DOI: 10.1242/jcs.249227

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  8 in total

1.  Plasma-derived extracellular vesicles transfer microRNA-130a-3p to alleviate myocardial ischemia/reperfusion injury by targeting ATG16L1.

Authors:  Sisi Yu; Xuepei Tang; Tian Zheng; Shuhao Li; Haibo Ren; Hailong Wu; Fei Peng; Lianggeng Gong
Journal:  Cell Tissue Res       Date:  2022-05-03       Impact factor: 5.249

Review 2.  Autophagy regulation by RNA alternative splicing and implications in human diseases.

Authors:  Patricia González-Rodríguez; Daniel J Klionsky; Bertrand Joseph
Journal:  Nat Commun       Date:  2022-05-18       Impact factor: 17.694

3.  Perturbation of ATG16L1 function impairs the biogenesis of Salmonella and Coxiella replication vacuoles.

Authors:  Nicole Lau; David R Thomas; Yi Wei Lee; Leigh A Knodler; Hayley J Newton
Journal:  Mol Microbiol       Date:  2022-01-04       Impact factor: 3.501

4.  Rabaptin5 targets autophagy to damaged endosomes and Salmonella vacuoles via FIP200 and ATG16L1.

Authors:  Valentina Millarte; Simon Schlienger; Simone Kälin; Martin Spiess
Journal:  EMBO Rep       Date:  2021-10-26       Impact factor: 8.807

5.  ATG16L1 is a Potential Prognostic Biomarker and Immune Signature for Osteosarcoma: A Study Based on Bulk RNA and Single-Cell RNA-Sequencing.

Authors:  Zhaojie Qin; Kai Luo; Wenyu Feng; Xinli Zhan; Yun Liu; Shijie Liao; Juliang He; Mingwei He; Tianyu Xie; Xiaohong Jiang; Boxiang Li; Huijiang Liu; Qian Huang; Haijun Tang
Journal:  Int J Gen Med       Date:  2022-02-02

6.  M6A-mediated upregulation of circMDK promotes tumorigenesis and acts as a nanotherapeutic target in hepatocellular carcinoma.

Authors:  Ashuai Du; Shiqin Li; Yuzheng Zhou; Cyrollah Disoma; Yujie Liao; Yongxing Zhang; Zongpeng Chen; Qinglong Yang; Pinjia Liu; Sixu Liu; Zijun Dong; Aroona Razzaq; Siyi Tao; Xuan Chen; Yuxin Liu; Lunan Xu; Qianjun Zhang; Shanni Li; Jian Peng; Zanxian Xia
Journal:  Mol Cancer       Date:  2022-05-06       Impact factor: 41.444

7.  Associations between ATG16L1 gene polymorphism and antineutrophil cytoplasmic antibody-associated vasculitis in the Chinese Guangxi population: A case-control study.

Authors:  Bing-Mei Feng; Chao Xue; Hai-Zheng Huang; Yu-Gan Lu; Tao Feng; Xue-Yi Huang; Wei Li
Journal:  J Clin Lab Anal       Date:  2022-08-10       Impact factor: 3.124

Review 8.  Pharmacogenetics of Biological Agents Used in Inflammatory Bowel Disease: A Systematic Review.

Authors:  Rita Lauro; Federica Mannino; Natasha Irrera; Francesco Squadrito; Domenica Altavilla; Giovanni Squadrito; Giovanni Pallio; Alessandra Bitto
Journal:  Biomedicines       Date:  2021-11-23
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.